CRP and irritable bowel syndrome: At the systemic level, chronic unregulated substance use is associated with alterations in inflammatory biomarkers, including C-reactive protein (CRP), IL-6, TNF-α, and hematological parameters such as neutrophil/lymphocyte ratio (NLR), systemic immune inflammation index (IBS), and white blood cell count [6,7,8].